Animation - Treatment and Management of NSCLC

Slide Show - Treatment and Management of NSCLC

Animation - Treatment and Management of SCLC

Slide Show - Treatment and Management of SCLC

Expert Videos

1. What kind of surgery is used for Non-Small Cell Lung Cancer (NSCLC)?

2. What factors determine the extent of lung cancer surgery?

3. Is surgery an option for small cell lung cancer?

4. What is chemotherapy? When is it needed?

5. What is radiation therapy? When is it needed?

6. What is targeted therapy? When is it needed?

7. What is immune therapy? When is it needed?

8. What is genomic testing? And why is it needed?

9. What is a clinical trial?

10. Is a “Placebo” always used in a controlled clinical trial?

11. When would a patient with lung cancer consider “Palliative Care”?

12. What should a patient think when their doctor says: “We do not want to do surgery”?

13. What is a “lobectomy”?

14. What is a lung ablation?

15. Can you have lung ablation after radiation therapy?

16. What is “percutaneous ablation”?

17. What is a “wedge surgery”?

18. What are “lung sparing techniques”?

19. What is a segmentectomy?

20. What is an EGFR mutation for lung cancer?

Expert Video - What is a segmentectomy?

A segmentectomy is a surgical procedure that removes the basic segment unit of the lung. It is a more difficult type of surgery to perform than a “wedge resection”. The goal is to balance the best possible surgery for the patient with maximizing the lung function after the surgery.

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.

Immunotherapy for Lung Cancer

Targeted Therapy in Non-Small Cell Lung Cancer

Understanding Non-Small Cell Lung Cancer (NSCLC)

Understanding Small Cell Lung Cancer (SCLC)

Screening for Lung Cancer

Lung Cancer Screening for Black Americans

Lung Cancer Screening for Native Americans

Diagnosis and Screening of Lung Cancer

Staging of Lung Cancer

Understanding Biomarker Testing in Non-Small Cell Lung Cancer

Understanding Clinical Trials in Lung Cancer

Lung Cancer Clinical Trials and the US Black Community

Lung Cancer Clinical Trials and Native Americans

NSCLC Treatment When You Have an EGFR Mutation

NSCLC Treatment Options When You Have an EGFR Mutation

NSCLC Treatment When You Have a KRAS Mutation

NSCLC Treatment Options When You Have a KRAS Mutation

NSCLC Treatment for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET

Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers

Understanding Prehabilitation for Lung Cancer Surgery

Your Prehabilitation Plan for Lung Cancer Surgery

Section: Treatment and Management of Lung Cancer

Animation - Treatment and Management of NSCLC

Slide Show - Treatment and Management of NSCLC

Animation - Treatment and Management of SCLC

Slide Show - Treatment and Management of SCLC

Expert Videos

1. What kind of surgery is used for Non-Small Cell Lung Cancer (NSCLC)?

2. What factors determine the extent of lung cancer surgery?

3. Is surgery an option for small cell lung cancer?

4. What is chemotherapy? When is it needed?

5. What is radiation therapy? When is it needed?

6. What is targeted therapy? When is it needed?

7. What is immune therapy? When is it needed?

8. What is genomic testing? And why is it needed?

9. What is a clinical trial?

10. Is a “Placebo” always used in a controlled clinical trial?

11. When would a patient with lung cancer consider “Palliative Care”?

12. What should a patient think when their doctor says: “We do not want to do surgery”?

13. What is a “lobectomy”?

14. What is a lung ablation?

15. Can you have lung ablation after radiation therapy?

16. What is “percutaneous ablation”?

17. What is a “wedge surgery”?

18. What are “lung sparing techniques”?

19. What is a segmentectomy?

20. What is an EGFR mutation for lung cancer?

This educational activity has been developed by A Breath of Hope Lung Foundation and Mechanisms in Medicine Inc.

This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Foundation Inc., Bristol-Myers Squibb Grants and Giving, Foundation Medicine, Genentech, Jazz Pharmaceuticals, Merck Sharp & Dohme LLC, Neogenomics, Novartis, Pfizer, and Takeda Oncology.

This website is part of the Animated Patient^® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed shared decisions, and partner with their healthcare professionals for optimal outcomes.